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Abstract High dietary fat causes increased bile acid
secretion into the gastrointestinal tract and is associated
with colon cancer. Since the bile acid deoxycholic acid
(DOC) is suggested to be important in colon cancer etiol-
ogy, this study investigated whether DOC, at a high
physiologic level, could be a colon carcinogen. Addition of
0.2% DOC for 8–10 months to the diet of 18 wild-type
mice induced colonic tumors in 17 mice, including 10 with
cancers. Addition of the antioxidant chlorogenic acid at
0.007% to the DOC-supplemented diet significantly
reduced tumor formation. These results indicate that a high
fat diet in humans, associated with increased risk of colon
cancer, may have its carcinogenic potential mediated
through the action of bile acids, and that some dietary anti-
oxidants may ameliorate this carcinogenicity.
Keywords Colon cancer  Deoxycholate 
Adenocarcinoma  Chlorogenic acid
Introduction
The primary cause of sporadic colorectal cancer appears to
be diet, although inherited mutations and smoking are also
risk factors. In human populations, colon cancer develop-
ment is associated with a high fat diet (Drasar and Irving
1973; Knox 1977; Miller et al. 1983; McKeown-Eyssen
and Bright-See 1984; Willett 1989; Willett et al. 1990;
Hursting et al. 1990; Butler et al. 2009). When a high fat
diet is fed to cancer prone Apcmin/? mice, a significant
increase in intestinal tumors is observed (Wasan et al.
1997). A Western-style diet containing a high level of
lipids and a low level of calcium and vitamin D induces
colonic tumors in normal mice (Newmark et al. 2001,
2009; Yang et al. 2008). These studies implicate dietary fat
in the etiology of human colorectal cancer. However, it
should be noted that the type of fat is also important, as
omega-3 polyunsaturated fatty acids are reported to
decrease colon cancer incidence (La Vecchia 2009; Tavani
et al. 2003).
The bile acids deoxycholic acid (DOC) and lithocholic
acid are increased in the colonic contents of humans in
response to a high fat diet (Reddy et al. 1980). The increase
in these bile acids presumably reflects increased deposition
of bile acids in the gastrointestinal tract in order to emul-
sify the increased level of dietary fat. In populations with a
high incidence of colorectal cancer, fecal concentrations of
bile acids are increased (Hill 1990; Cheah 1990; Hill et al.
1982; Crowther et al. 1976; Reddy and Wynder 1973;
Reddy et al. 1978; Jensen et al. 1982), suggesting that
increased exposure of the colonic lumen to high levels of
bile acids plays a role in the natural course of development
of colon cancer. In addition, Bayerdorffer et al. (1995)
reported a positive association between DOC in the serum
and colorectal adenomas, the precursors of colorectal
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cancer, further indicating a pathogenic role of DOC in
colonic carcinogenesis. The hydrophobic bile acids, DOC
and lithocholic acid, appear to be the most significant bile
acids with respect to human colorectal cancer (Hill 1990).
In addition to evidence from population studies (Hill
1990; Cheah 1990; Hill et al. 1971, 1982; Crowther et al.
1976; Reddy and Wynder 1973; Reddy et al. 1978; Jensen
et al. 1982), experimental evidence also strongly indicates
an etiologic role of bile acids in colon cancer. Figure 1
indicates the mechanism by which high levels of bile acids
in the colon could lead to colon cancer. Exposure of colon
cells to high physiologic concentrations of DOC induces
formation of reactive oxygen and nitrogen species
(Lechner et al. 2002; Crowley-Weber et al. 2003; Casellas
et al. 1996; Venturi et al. 1997; Booth et al. 1997; Washo-
Stultz et al. 1999, 2002; Payne et al. 2007; Longpre and
Loo 2008; Dall’Agnol et al. 2006; Craven et al. 1986;
Bernstein et al. 2006) and DNA damage (Venturi et al.
1997; Booth et al. 1997; Longpre and Loo 2008; Bernstein
et al. 2006; Payne et al. 1998; Rosignoli et al. 2008; Booth
and Bilton 1998; Powolny et al. 2001; Glinghammar et al.
2002; Romagnolo et al. 2003) (Fig. 1). The DNA damage
induced by DOC is, in part, oxidative DNA damage
(Venturi et al. 1997; Bernstein et al. 2006; Rosignoli et al.
2008). Deficiency in base excision repair of oxidative DNA
damage is linked to increased risk of intestinal tumors in
mice (Sakamoto et al. 2007) and of colon cancer in humans
(Jenkins et al. 2006). That DOC induces DNA damage in
colon cells suggests that bile acids may also cause mutation
(Fig. 1) when replication occurs past the damage. Recently,
we showed that DOC causes aneuploidy and micronuclei
formation, indicators of genomic instability, in colon epi-
thelial cells (Payne et al. 2008, 2010a). Furthermore, per-
sistent exposure of cultured colon epithelial cells to DOC
results in altered expression of chromosomal maintenance/
mitosis-related genes that might account, in part, for the
observed genomic instability (Payne et al. 2008, 2010a;
Crowley-Weber et al. 2002; Bernstein et al. 2004).
Numerous studies have shown that DOC induces apop-
tosis in colon cells in short-term cultures (Fig. 1) (e.g.
Washo-Stultz et al. 1999; Longpre and Loo 2008; Booth and
Bilton 1998; Glinghammar et al. 2002; Sakamoto et al.
2007; Payne et al. 1995; Garewal et al. 1996; Bernstein et al.
1999, 2002). Induction of apoptosis after cells encounter
DOC may protect against the survival of cells with damaged
template DNA that, upon replication, might undergo
mutation leading to cancer. In the long-term, however,
repeated exposure of colonic epithelial cells to high physi-
ologic concentrations of bile acids appears to select for cells
that are resistant to induction of apoptosis by bile acids
(Payne et al. 1995, 2007; Garewal et al. 1996; Bernstein
et al. 1999, 2002) (Fig. 1). Epithelial cells of colonic origin
that were grown in culture and repeatedly exposed to
increasing concentrations of DOC developed resistance to
apoptosis. These apoptosis-resistant cells were altered in
expression in 839 out of 5,000 genes assessed by cDNA
assay (Crowley-Weber et al. 2002) and in 91 of 454 proteins
detected by a proteomic analysis (Bernstein et al. 2004). The
autophagic survival pathway was also determined to be
responsible, in part, for the observed apoptosis resistance of
these cells (Fig. 1) (Payne et al. 2009). Apoptosis-resistant
cells might arise in vivo through mutation (or epimutation)
and clonally expand through natural selection to form a field
of resistant cells (Fig. 1). Evidence for such a ‘‘field
change’’ is the observation that expression of the anti-
apoptotic protein Bcl-xL is increased in the colon mucosa
adjacent to adenocarcinomas (Badvie et al. 2006). Also a
variant of the ileal bile acid binding protein, referred to as
IBABP-L, is up-regulated in colorectal cancer and is nec-
essary for resistance of these cancer cells to hydrophobic
bile acids (Fang et al. 2007), indicating that resistance to bile
acid-induced apoptosis plays a role in colon carcinogenesis.
The findings briefly reviewed above suggest that fre-
quent stimulation of bile acid deposition into the gastro-
intestinal tract, due to elevated dietary fats/oils, plays a key
role in the induction of colonic tumors. Recently we
reported that exposure of mouse colon to dietary DOC
induced colitis (Bernstein et al. 2006, 2007) and sessile
adenomas (Payne et al. 2010b). We also showed that die-
tary DOC modulated the expression of at least 95 mouse
genes at the mRNA level, including genes involved in the
Fig. 1 Role of bile acids in progression to cancer
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processes of inflammation, angiogenesis, epithelial barrier
function, oxidative stress, apoptosis, cell proliferation/cell
cycle/DNA repair, membrane transport and the ubiquitin–
proteasome pathway (Bernstein et al. 2006). In the present
study, we report that DOC not only induces adenomas, but
also invasive cancers. We also present evidence that die-
tary chlorogenic acid (high in coffee, blueberries, eggplant




Mice were maintained at the University of Arizona’s
Animal Care Facility. Wild-type male B6.129PF2/J mice
were obtained from Jackson Laboratories (Bar Harbor,
ME). All animals were raised in cages under non-sterile
micro-isolator conditions and in compliance with the reg-
ulations and NIH guidelines for Care and Use of Labora-
tory Animals.
The mice were free of murine viruses, pathogenic bac-
teria (including Helicobacter spp.), and endo- and ecto-
parasites by routine health evaluations. The mice were
maintained on a 12-hr light–dark cycle with water ad libi-
tum and fed a purified AIN-93G diet, either non-supple-
mented (diet 1), supplemented with 0.2% DOC (diet 2),
0.007% chlorogenic acid (CGA) (diet 3), or 0.2%
DOC ? 0.007% CGA (diet 4). The purified diets were
prepared by Harlan Teklad (Madison, WI). The AIN-93G
diet components and analysis are shown in Table 1. Mice
were fed the diets starting at 5 weeks of age and continuing
until termination. Mice were sacrificed using CO2 at 8 or
10 months of feeding.
Histopathology and photography
The whole colon was removed, opened longitudinally,
rinsed with phosphate-buffered saline, divided into 3 seg-
ments, the segments were placed flat on a Matricel mem-
brane for orientation, photography of opened segments was
performed on some segments with a Sony Cybershot 7.2
megapixel camera, segments were fixed in 10% formalin
overnight at 4C, transferred to 70% alcohol, and embed-
ded in paraffin.
Then 4 micron tissue sections were cut and placed on a
slide for histopathological assessment after staining with
hematoxylin and eosin. Morphologic evaluation was per-
formed using a brightfield microscope (Nikon E400).
Representative images were captured digitally using a
Sony 3CCD color videocamera and ImagePro software
(Media Cybernetics, Silver Spring, MD).
Measurement of DOC in the feces
DOC was measured in the mixed feces of four mice on each
of two diets (control, diet ? DOC) after 90 days on their
diets. Similar to the method described by Post et al. (2003),
fecal production during a 1-day period was separated from
the bedding, fecal samples were frozen at -80C, lyophi-
lized, and for analysis of bile acids, an aliquot of dried feces
(5 mg) was used. The feces were analyzed for bile acids by
a standard method used previously in the core facilities at
the Arizona Cancer Center for measuring DOC in human
feces (Alberts et al. 2005; Wertheim et al. 2009). The dried
feces were incubated in 1 ml alkaline methanol (methanol:
1 mol/L NaOH 3:1 [vol/vol]) for 2 h at 80C in screw-
capped tubes, using added norcholic acid as an internal
standard. The procedure was then continued as described
(Alberts et al. 2005; Wertheim et al. 2009) using a Thermo-
Finnigan TSQ Quantum triple quadrupole mass spectrometer
in tandem with a Surveyor LS system.
Data analysis
As the data was non-normally distributed, the nonpara-
metric Mann–Whitney U test was used to test for differ-
ences between diets.
Results
Mice were fed either a control non-supplemented diet (diet 1),
a diet supplemented with 0.2% DOC (diet 2), a diet









AIN-93G mineral mix 35.000







Metabolizable energy 3.97 kcal/gm
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supplemented with 0.007% chlorogenic acid (CGA) (diet 3)
or a diet supplemented with both DOC and CGA (diet 4). The
presence of DOC in the feces of 4 mice on the control diet and
4 mice on the diet ? DOC was measured after 90 days on
their diets. The level of DOC in feces from mice on the control
diet was 0.3 mg DOC/g dry weight, while the level of fecal
DOC for mice on the diet ? DOC was 4.6 mg DOC/g dry
weight.
The mice fed each of the 4 diets had colons that, in most
areas, appeared to be morphologically normal (Fig. 2).
However, the wild-type mice fed a diet supplemented with
0.2% DOC (diet 2) frequently developed tumors that could
be seen macroscopically when the mouse colons were
opened (Fig. 3). Mouse tumors after 8 months on the
DOC-supplemented diets, when viewed macroscopically,
appeared to be more distinct, with more defined borders
than tumors seen after 10 months on a DOC-supplemented
diet, when tumors appeared to have less defined margins
and were often more spread out (broad based or sessile).
When hematoxylin and eosin stained sections were
viewed by brightfield microscopy, sessile adenomas, ses-
sile-serrated adenomas (Fig. 4 panels A, B) and adeno-
carcinomas (Fig. 4 panels C, D) could be identified
histopathologically in the colons of mice whose diets were
supplemented with DOC or DOC ? CGA for 8 or
10 months (Table 2).
As shown in Table 2, 17 of 18 mice (94%) fed the DOC
supplemented diet for 8 or 10 months developed tumors
(adenomas or cancers), and of these DOC-fed mice, 10
(56%) had developed cancers. The 12 mice without any
supplement to their diet had no tumors or cancers. At 8 and
10 months, there were significant differences in the number
of mice with tumor development between those fed a
DOC-supplemented diet and those fed no supplements
(8-month Mann–Whitney U = 0.00, n1 = 12, n2 = 6,
P \ 0.001 two-tailed; 10-month Mann–Whitney U = 3.00,
n1 = 6, n2 = 6, P = 0.005 two-tailed). Similarly, the
development of cancers in DOC fed mice compared to the
non-supplemented mice was clearly significant at both 8
and 10 months (8-month Mann–Whitney U = 18.00,
n1 = 12, n2 = 6, P = 0.039 two-tailed; 10-month Mann–
Whitney U = 6.00, n1 = 6, n2 = 6, P = 0.019 two-
tailed).
When CGA at 0.007% (a level equivalent to 3 cups of
coffee a day in humans (Clifford 1999)) was added along
with DOC (DOC ? CGA diet), the number of mice that
developed tumors was significantly reduced in comparison
to the mice on a diet supplemented with DOC alone at
8 months, but not at 10 months (8-month Mann–Whitney
U = 24.00, n1 = 12, n2 = 6, P = 0.039 two-tailed;
10-month Mann–Whitney U = 11.50, n1 = 6, n2 = 5,
P = 0.409 two-tailed). The tumor burden in the DOC-fed
mice at 8 months was 1.6 times the tumor burden in the
DOC ? CGA-fed mice (Table 2), and the cancer burden in
the DOC-fed mice at 8 months was 3 times the cancer
burden in the DOC ? CGA-fed mice (Table 2).
The frequency of mice with tumors was significantly
higher on the DOC ? CGA diet vs. no supplement at both 8
and 10 months (8-month Mann–Whitney U = 6.00,
n1 = 6, n2 = 6, P = 0.019 two-tailed; 10-month Mann–
Whitney U = 6.00, n1 = 5, n2 = 6, P = 0.034 two-tailed),
but the frequency of mice with cancers was not significantly
different at 8 or 10 months (8-month Mann–Whitney
U = 15.00, n1 = 6, n2 = 6, P = 0.317 two-tailed;















DOC 8 12 12 (100%) 6 (50%) 16 (1.3) 7 (0.6)
10 6 5 (83%) 4 (67%) 13 (2.2) 8 (1.3)
Total 18 Total 17 (94%) Total 10 (56%) Total 29 (1.6) Total 15 (0.83)
DOC ? CGA 8 6 4 (67%) 1 (17%) 5 (0.8) 1 (0.2)
10 5 3 (60%) 1 (20%) 5 (1.0) 1 (0.2)
Total 11 Total 7 (64%) Total 2 (18%) Total 10 (0.9) Total 2 (0.2)
CGA 8 6 0 0 0 0
10 6 0 0 0 0
Total 12 Total 0 Total 0 Total 0 Total 0
None 8 6 0 0 0 0
10 6 0 0 0 0
Total 12 Total 0 Total 0 Total 0 Total 0
DOC deoxycholate, CGA chlorogenic acid
** Tumor burden is the ratio of the number of tumors observed to the number of mice
*** Cancer burden is the ratio of the number of cancers observed to the number of mice
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Fig. 2 Normal areas of colons
of mice from 4 different dietary
groups. Diet supplements fed
for 10 months: a none; b CGA;
c DOC; d DOC ? CGA.
Images taken at 2009
magnification. Bars show
0.2 mm. H&E staining
Fig. 3 Opened mouse proximal
colon segments showing tumors
after feeding the DOC-
supplemented diet. Each opened
colon segment is shown (top
images), with the
macroscopically observed
tumors identified with closed
dashed curves (bottom images).
Left images: 8 months on diet;
Right images: 10 months on diet
Fig. 4 Two areas of mouse
colonic mucosa with sessile
serrated adenomas (a, b) and
two areas with adenocarcinomas
(c with a stage T1, and d with a
stage T2 cancer). From mice fed
the DOC supplemented diet for
10 months. Images taken at
2009 magnification. Bars show
0.2 mm. H&E staining
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10-month Mann–Whitney U = 9.00, n1 = 5, n2 = 6, P =
0.102 two-tailed).
Similarly, the frequency of mice with tumors on the
DOC ? CGA diet was significantly higher than the fre-
quency of mice with tumors on the CGA diet alone at both
8 and 10 months (8-month Mann–Whitney U = 6.00,
n1 = 6, n2 = 6, P = 0.019 two-tailed; 10-month Mann–
Whitney U = 6.00, n1 = 5, n2 = 6, P = 0.034 two-
tailed), but the frequency of mice with cancers was not
significantly different at 8 or 10 months (8-month Mann–
Whitney U = 15.00, n1 = 6, n2 = 6, P = 0.317 two-tailed;
10-month Mann–Whitney U = 9.00, n1 = 5, n2 = 6, P =
0.102 two-tailed).
All of the tumors in the DOC-fed mice were in the same
region, the proximal colon. Furthermore, all of the tumors
were sessile, and 71% of these were sessile-serrated ade-
nomas or adenocarcinomas arising from sessile serrated
adenomas. Of the 17 cancers observed (15 in the DOC fed
mice, and 2 in the DOC ? CGA fed mice), all appeared to
arise from sessile-serrated adenomas. The adenocarcino-
mas were classified with regard to the extent of spread
through the layers that form the wall of the colon. Fourteen
(82%) of the adenocarcinomas were in category T1 (the
cancer had grown through the muscularis mucosa and
extended into the submucosa) (Fig. 4c), and 3 (18%) of the
adenocarcinomas were T2 (the cancer had grown through
the submucosa and into the muscularis propria) (Fig. 4d).
All tumors were found in the colon. No tumors were
observed in the small intestine.
Body weights of the mice fed the diets plus supplements
(DOC, DOC ? CGA, or CGA) did not differ from body
weights of mice fed the non-supplemented AIN-93G diet.
Discussion
Early experiments on rats showed that bile acids can act as
promoters, enhancing the incidence of tumors when a
potent carcinogen was also administered (Narisawa et al.
1974; Reddy et al. 1976, 1977; McSherry et al. 1989).
However, in these previous rat experiments, bile acid
treatment alone did not induce tumors. In the first of these
studies (Narisawa et al. 1974) the bile acids lithocholic and
taurodeoxycholic acid were administered intrarectally; in
the second study (Reddy et al. 1976) DOC was adminis-
tered intrarectally to germ free rats; in the third study
(Reddy et al. 1977) cholic acid and chenodeoxycholic acid
were administered intrarectally; and in the fourth study
(McSherry et al. 1989) cholic acid was fed, but only over a
6 month period. These prior experiments differed from
those reported here in several ways [i.e. rats vs. mice;
intrarectal vs. dietary (oral) administration; various other
bile acids vs. DOC; germ free vs. conventional rodents;
6 months vs. 8–10 months of exposure]. Thus, there is no
inconsistency between these early negative results and the
positive results reported here, where adding DOC to the
diet of mice for 8–10 months caused development of colon
cancer.
All of the tumors found in this study were in the prox-
imal colon of the mice. In humans, however, tumors are
found both in the proximal and distal regions of the colon.
The level of DOC in the different regions of the human
colon depends on two factors. The first factor is the con-
tinuous deconjugation and dehydroxylation (by bacteria) of
the cholic acid entering from the small intestine, which
forms new DOC throughout the length of the colon
(Thomas et al. 2001). The second factor is the high level of
absorption (about 50% overall) of DOC as it passes along
all the regions of the colon (Samuel et al. 1968). In our
mice, the level of DOC (from the diet of our diet ? DOC
fed mice) is already high in the proximal region of the
colon. Conversion of cholic acid to DOC would be rela-
tively insignificant for these mice since about 90% of the
DOC in the colons of our mice fed diet ? DOC comes
from the added DOC in the diet. Presumably, there is
similar absorption of DOC from all regions of the colon in
mice, as occurs in humans. Thus, there should be higher
levels of DOC in the proximal colons of our mice com-
pared to the levels of DOC in their distal colons. In our
mice, much of the DOC would be absorbed as it travels
down the length of the mouse colon. If tumors are caused
by interaction of relatively high levels of DOC with colonic
epithelial cells, then it is likely that, in our system, most
tumors would occur in the proximal colons of the mice,
while in humans, with a more even distribution of DOC
along the colon, tumors would occur in both the proximal
and distal regions of the colon.
All the tumors we observed were of the sessile type, and
most were sessile-serrated. In humans, about 9% of colonic
tumors found by colonoscopy are sessile-serrated adeno-
mas (Spring et al. 2006). Patients with a sessile-serrated
adenoma were estimated to develop a subsequent adeno-
carcinoma at a rate of 5.3%, compared with a rate of 2.2%
for conventional adenoma patients (Noffsinger 2009).
The dietary level of DOC used in this study (0.2%) to
induce colon adenomas and colonic adenocarcinomas
produced a level of DOC in dried feces, after 90 days on
diet ? DOC, of 4.6 mg DOC/g dry weight, while the level
of DOC in dried feces from mice on the control diet for
90 days was 0.3 mg DOC/g dry weight.
For humans on a non-controlled omnivorous diet the
level of DOC in the feces varies from 2.3 mg/g dry weight
to 4.1 mg/g dry weight with a mean of 3.2 mg/g dry weight
(Reddy et al. 1998). Two different experimental high fat
diets in humans raised levels of DOC in the feces by
approximately a factor of 2, compared to humans eating a
868 Arch Toxicol (2011) 85:863–871
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non-intervention diet (Reddy et al. 1980; Stadler et al.
1988). Thus, a high fat human diet would subject humans
to colonic exposure to DOC at an average value in their
feces of 2 9 3.2 mg/g = 6.4 mg/g dry weight, a level that
is similar to the level of colonic exposure to DOC in our
mice fed a DOC-supplemented diet (4.6 mg DOC/g dry
weight in their feces). These levels of DOC in the feces of
humans and mice were evaluated by use of a mass spec-
trometer. Such evaluations do not discriminate between
conjugated and non-conjugated bile acid concentrations,
and thus could overestimate the total amount of non-con-
jugated DOC in the feces. However, as shown by Reddy
et al. (1998), conjugated bile acids were 0.75 mg/g dry
weight in omnivores while free bile acids were 7.48 mg/g
dry weight. Since conjugated bile acids are only a small
fraction of the total bile acids in the colon [0.75/
(7.48 ? 0.75) = 0.09] our comparison of the level of DOC
in the feces of humans and mice is not significantly
changed.
Both of the experimental high fat human diets specified
consumption of about 120 g (4.3 oz) per day of fat, either
from whole milk products and beef (Reddy et al. 1980) or
from corn oil (Stadler et al. 1988). This is comparable to
the daily fat consumption of present-day Americans who
consume at the high end of the spectrum of high-fat diets
[this could be over 150 grams (5.3 oz) of fat per day]. Such
individuals would likely be exposed to increased levels of
DOC in their colons, comparable to the levels to which our
DOC-fed mice were exposed.
DOC is a natural endogenous agent increased in the
colonic contents of humans in response to a high fat diet.
Our results show that DOC can act as a carcinogen. These
findings mesh with a substantial body of epidemiological
findings, as well as experimental evidence at the cellular
level, which also indicate that bile acids have a major
etiologic role in colon cancer in humans (reviewed in the
Introduction, above, and more extensively in Jenkins et al.
2006; Bernstein et al. 2005, 2009).
The finding that chlorogenic acid, added to the DOC-
supplemented diet of 11 mice, significantly reduced tumor
development suggests that chlorogenic acid may prove to
be effective in inhibiting tumor development in humans.
Such a potential effect is also suggested by the finding for
humans, in two large prospective cohort studies, of an
approximately twofold lower risk of rectal cancer associ-
ated with regular consumption of decaffeinated coffee
(Michels et al. 2006). Coffee has a high level of chloro-
genic acid (Clifford 1999; Mattila and Kumpulainen 2002).
Chlorogenic acid has antioxidant activity in vitro and
consumption of blueberries high in chlorogenic acid,
increased plasma antioxidant capacity by 15% (Fernandez-
Panchon et al. 2008). Further, chlorogenic acid protects
DNA against oxidative damage in vitro (Tang and Liu
2008). Chlorogenic acid does not confer chemoprotection
against azoxymethane-induced colon carcinogenesis in
mice (Park et al. 2010). Thus it appears that chlorogenic
acid is protective in the likely naturally occurring DOC-
induced pathway to colon cancer, but not in the
azoxymethane-induced colon carcinogenesis pathway,
which may not be similar to the natural pathway. Overall,
our findings suggest that bile acids, at the high physiologic
levels and long-term exposures associated with a high fat
Western diet, may act as carcinogens in the development of
colon cancer in humans, and that chlorogenic acid may
ameliorate this effect.
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